Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Discover when it’s advisable to keep cash instead of opting for bank deposits. This information will help you manage your money wisely.
23,560 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
When a tech giant pours billions into warehouse robotics, investors want to know what happens next. This guide breaks...
Tech stocks pulled back this week as margin risk reemerged amid a cooling chip cycle. Investors who bet on leverage w...
As Amazon prepares for its next earnings release, a provocative scenario targets Andy Jassy and AWS. This piece break...
In 2026, California's counties with highest property taxes are seeing bills rise as high-valued homes push costs up, ...
Nvidia just beat earnings expectations, yet the stock fell in the following days. This article breaks down what the p...
A noteworthy fund increased its Celcuity stake by 135,000 shares, signaling potential catalysts and shifting risk. Le...
Geopolitics can tip energy costs, and that ripple reaches AI markets. Learn how the Iran conflict briefly sent oil pa...
PayPal’s plunging stock drags down YieldMax’s PYPY, with weekly distributions shrinking as Q4 2025 missed expectation...
A wave of new positions from hedge funds loading boeing points to a cautious but growing bet that Boeing can rebound ...
The U.K. edition of Saturday Night Live is renewed for a second season, underscoring a new model where social-clip vi...
A three-way push for space-based AI puts Elon Musk and Jeff Bezos in a high-stakes orbit with a rising rival coalitio...